Evidence-Based Consensus on the Clinical Application of Photobiomodulation (PBM)

Summary

This article presents an evidence-based consensus review on the safe and effective clinical use of Photobiomodulation (PBM), also known as low-level light therapy. The goal was to provide clearer guidance for clinicians because PBM has been used across many medical and dermatologic conditions, but treatment protocols have often been inconsistent.

Key Findings

• PBM shows promise as a non-invasive therapy that can support healing, reduce inflammation, and improve tissue repair.
• It may help stimulate cellular metabolism, circulation, collagen production, and tissue regeneration.
• Clinical applications discussed include wound healing, pain reduction, inflammatory skin conditions, and recovery after tissue injury.
• The review emphasized the importance of safe dosing, wavelength selection, and treatment consistency for better outcomes.

Clinical Importance

This consensus helps create a more standardized framework for PBM use in clinical practice, especially in dermatology and regenerative medicine, where treatment settings can vary significantly.

Limitations

• Evidence quality varied across studies.
• Some applications still need stronger randomized controlled trials.
• Standardized protocols for wavelength, energy dose, and treatment duration are still evolving.

Conclusion

PBM is considered a promising adjunctive therapy with potential benefits in healing, pain management, and tissue repair. However, proper clinical guidelines and standardized treatment parameters are essential for safe and effective use.

Simple takeaway: This paper supports PBM as a useful light-based therapy in medicine and dermatology, but effectiveness depends on using evidence-based treatment protocols.